SCHEMBL7986940

SCHEMBL7986940

Cc1c(C(=S)Nc2cccc(Cl)c2)nnn1-c1ccc(F)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
ALDH1A1 P00352 4/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
POLB P06746 2/20 0.52
MET P08581 2/20 0.46
KDR P35968 1/20 0.42
TP53 P04637 2/20 0.41
SMURF1 Q9HCE7 1/20 0.40
THRB P10828 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
GRM5 P41594 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407140 0.87 MAPT (0.60) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3400866 0.80 MAPT (0.58) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3407265 0.76 MAPT (0.65) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3403988 0.75 SMN1; SMN2 (0.64) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3406096 0.74 MAPT (0.62) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3401287 0.73 MET (0.63) MAPTALDH1A1SMN1; SMN2POLBMET
SCHEMBL3404285 0.73 MET (0.63) MAPTALDH1A1SMN1; SMN2POLBMET
SCHEMBL8001635 0.73 MAPT (0.58) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3403675 0.72 MAPT (0.78) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3407283 0.71 SMURF1 (0.59) MAPTALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009115486-A1 TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2009-09-24 WO disclosed